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Abstract
Background Although high rates of depression
symptoms are reported in adults with intellectual
disabilities (IDs), there is a lack of knowledge about
non-pharmacological treatment options for depres-
sion in this population. The ﬁrst research question of
this paper is: Which non-pharmacological interven-
tions have been studied in adults with ID and de-
pression? The second research question is: What were
the results of these non-pharmacological
interventions?
Method Systematic review of the literature with an
electronic search in six databases has been completed
with hand searches. Preferred Reporting Items for
Systematic Reviews and Meta-analyses guidelines
have been followed. Selected studies met predeﬁned
inclusion criteria.
Results Literature search resulted in 4267 papers of
which 15 met the inclusion criteria. Five different
types of non-pharmacological interventions have been
studied: cognitive behavioural therapy, behavioural
therapy, exercise intervention, social problem-solving
skills programme and bright light therapy.
Conclusion There are only a few studies of good
quality evaluating non-pharmacological interventions
for adults with ID and depression. Some of these
studies, especially studies on cognitive behavioural
therapy, show good results in decreasing depressive
symptoms. High-quality randomised controlled trials
evaluating non-pharmacological interventions with
follow-up are needed.
Keywords depression, intellectual disabilities, non-
pharmacological interventions, systematic review
Background
Since the 1980s, there is awareness that psychiatric
disorders can co-occur with intellectual disabilities
(IDs) (Sovner & Hurley 1983; Marston et al. 1997;
Cooper et al. 2007; Hurley 2008; Hermans et al.
2013). Nowadays, we know that depression is a
common psychiatric disorder in adults with ID. The
prevalence range of depression in the ID population
varies from 2.2% to 7.6% (Deb et al. 2001; Smiley
2005; Cooper et al. 2007; Hermans et al. 2013). The
prevalence is higher compared with that in the
general population, despite the fact that depressive
symptoms can be difﬁcult to recognise in this
population (Marston et al. 1997; Hurley 2008;
Hermans et al. 2013). Depression is mainly
characterised by sadness and loss of interest or
pleasure (American Psychiatric Association 2013).
Depression has a major impact on the quality of life
(QoL) and leads to cognitive, social and physical
problems (Coryell et al. 1993; Hays et al. 1995; Bijl &
Ravelli 2000; Sprangers et al. 2000; Beekman et al.
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2; Alonso et al. 2004; Judd et al. 2008; Kober 2010;
Horovitz et al. 2014; Rand & Malley 2017). Horovitz
et al. (2014) found a signiﬁcantly higher QoL in a
group of adults with ID without Axis I diagnosis
compared with adults with ID in the anxiety/mood
disorder diagnosis group. Furthermore, adults with
ID with higher levels of anxiety/depression are more
likely to report a poor QoL (Rand & Malley 2017).
In the general population, antidepressants are
frequently prescribed to treat depressive symptoms.
Psychoactive medications, including antidepressants,
are regularly prescribed in adults with ID, primarily
to reduce challenging behaviour (Lott et al. 2004;
Deb et al. 2009; Matson & Mahan 2010; Sheehan
et al. 2015). There is some evidence that
antidepressant medication can decrease depressive
symptoms in adults with ID (Masi et al. 1997;
Verhoeven et al. 2001; Janowsky et al. 2005). For
example, in a group of 20 participants, Verhoeven
et al. (2001) found Citalopram effective in decreasing
depressive symptoms. Many adults with ID use
more than one medication, and polypharmacy is
common in adults with ID (Haider et al. 2014;
Häβler et al. 2015; Bowring et al. 2017). Negative
side effects (short term and long term) can appear
when psychoactive medications are used in adults
with ID (Deb et al. 2009; Mahan et al. 2010; Matson
& Mahan 2010; Eady et al. 2015; Häβler et al. 2015).
For example, physical complaints, neurological
damage, movement side effects and physiological
problems are mentioned (de Leon et al. 2009;
Matson & Mahan 2010; Sheehan et al. 2017).
Besides, adults with ID seem to be more amenable
to develop side effects compared with the general
population when psychoactive medications are used
(Arnold 1993; Matson & Mahan 2010; Sheehan et al.
2017). Moreover, it can take a while for a
psychoactive medication to work in the right daily
dosage, and adults with ID may experience even
more side effects when more than one psychotropic
medication is used (Matson & Mahan 2010).
Therefore, there is a need for evidence-based non-
pharmacological treatments for depression in adults
with ID.
In the general population, a wide range of
systematic reviews on non-pharmacological
interventions for depression have been published
over the last couple of years (Merry et al. 2011;
Cox et al. 2012; Catalan-Matamoros et al. 2016;
Kvam et al. 2016; Lee et al. 2016; Stubbs et al.
2016). Unfortunately, the conclusions of these
reviews (both positive and negative) cannot be
generalised to the ID population because a large
part of the non-pharmacological interventions for
depression of the general population are not
suitable for adults with ID. Next to cognitive
limitations, adults with ID frequently have verbal
limitations. Psychological interventions, for
example, cognitive behavioural therapy (CBT), are
too difﬁcult for adults with a more severe ID and
for those with verbal limitations. Furthermore, a
large part of people with ID have physical
limitations as well (Cooper et al. 2015).
Consequently, exercise interventions can be too
complicated to perform or physically impossible.
A few systematic reviews concerning non-
pharmacological interventions for depression for
adults with ID have been published. Some studies
are investigating interventions for a part of the ID
population. For example, Osugo & Cooper (2016)
focused on interventions for adults with mild ID and
mental ill health. They concluded that there was
some evidence for group CBT (although larger trials
are needed) but that in general the evidence-based
interventions for people with mild ID and mental
problems were limited. Koslowski et al. (2016)
investigated in their systematic review and meta-
analyses the effectiveness of interventions on mental
health problems in adults with mild to moderate ID.
They found no strong evidence for interventions
aimed at improving mental health problems,
including depression, and found a non-signiﬁcant
moderate effect size [d = 0.49, 95% conﬁdence
interval (CI)-0.05 to 1.03; P = 0.08] for depression
interventions (psychotherapy only). The focus of
other reviews in this research area is on speciﬁc
treatments only. For instance, Vereenooghe &
Langdon (2013) did a meta-analysis on psychological
therapies for people with ID and mental health
problems and found an overall moderate between-
group effect size (g = 0.682, 95% CI 0.379 to 0.985).
Furthermore, a subgroup meta-analysis indicated
that individually psychological therapy (g = 0.778,
95% CI 0.110 to 1.445) was more effective than
group-based psychological therapy (g = 0.558, 95%
CI 0.212 to 0.903) and psychological interventions
for depression had a moderate effect size (g = 0.742,
95% CI 0.116 to 1.599).
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Depression can occur in all levels of ID. Hence, an
overview of evidence-based non-pharmacological
interventions for depression for the whole ID
population is needed, as the severe and profound ID
population got no or little attention in previous
reviews. Therefore, the aim of this review is to
evaluate non-pharmacological treatments for adults
with ID (all levels) and depression. Our ﬁrst research
question is: Which non-pharmacological
interventions have been studied in adults with ID and
depression? Our second research question is: What
were the results of these non-pharmacological
interventions?
Method
We have used the Preferred Reporting Items for
Systematic Reviews and Meta-analyses checklist to
perform this study (Moher et al. 2009). The study is
registered in the PROSPERO database (PROSPERO
2016: CRD42016051524).
Data sources
An electronic search in six databases, Embase,
MEDLINE, Web of Science, Cochrane, PsycINFO
and Google Scholar, has been performed on 3
October 2016. The search strategy (for the databases
mentioned previously) is included in Appendix 1. The
electronic search has been completed with hand
searches in reference lists of recent systematic reviews
(published between January 2012 and 3 October
2016) and in reference lists of included papers.
Study selection
Inclusion criteria
Inclusion criteria have been clearly deﬁned before the
start of the study. All papers published in English
before 3 October 2016, mentioning non-
pharmacological interventions for treating depression
(of any type) or depressive symptoms in adults (aged
≥16 years) with ID (IQ ≤ 70), have been selected.
Outcome measures on depressive symptoms must be
mentioned in the paper to be included. Because the
aim of this study is to ﬁnd all non-pharmacological
interventions for adults with ID and depression, no
exclusion on type of study design has been made.
Therefore, all different kinds of study designs, from
case study to randomised controlled trial (RCT),
were included. The choice to include all study designs
contributes to the presentation of the current state of
evidence for the different types of non-
pharmacological interventions, and possible gaps of
knowledge can be exposed.
When a combined population of children and
adults was described in a paper, the results of the
adult population must be separately presented to be
included. The same applies to level of ID: when the
study population also contained adults with an IQ of
more than 70, the population with IQ ≤ 70 must be
separately presented to be included. In some papers,
combined interventions (pharmacological and non-
pharmacological) are described. Papers are only
included when the results of both of these
interventions are studied separately. (Systematic)
reviews of non-pharmacological interventions, as well
as narrative papers without results and congress
abstracts, were not included in the current review.
Process of the study selection
After identifying papers through the electronic search,
duplicates have been removed. Then, title and
abstract of the papers have been scanned by two
reviewers (PH and HH) independently, according to
the predeﬁned inclusion criteria mentioned
previously. After the selection of all relevant records
on title and abstract, the databases of the two
reviewers were merged to see if there was any
disagreement about included papers. Any
disagreement was solved by discussion in a consensus
meeting. Reference lists of recent systematic reviews
were studied by both reviewers (PH and HH) for
relevant studies. Hereafter, full texts of all remaining
papers have been assessed for eligibility by two
reviewers (PH and HH) independently. Hand
searches in reference lists of included papers were
done to search for relevant papers to include. The
potential relevant papers of both hand searches were
discussed by both reviewers (PH and HH) before
including the papers in the ﬁnal database. After this
step, the ﬁnal database was created. See Fig. 1 for the
ﬂow chart of the selection of studies. Data extraction
of the included studies has been performed by one
reviewer (PH) and checked by the second reviewer
(HH). See Tables 1a and 1b for details of the study
characteristics.
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Quality assessment of the included studies
To evaluate the quality of the included studies, the
Cochrane Risk of Bias Tool (Higgins & Green
2011) has been used by two reviewers
independently (PH and HH), and any
disagreement has been discussed in a second
consensus meeting. With this tool, six domains
were assessed to evaluate the quality of the
included studies: selection bias, performance bias,
detection bias, attrition bias, reporting bias and
possible other bias. Low risk of a speciﬁc bias is
rated with a ‘+’. For example, there is a low risk
of performance bias when participants and
researchers do not know which intervention the
participant will receive (blinding). When there is a
high risk of a speciﬁc bias, that bias is marked
with a ‘’. For example, when there is a high risk
of selection bias because of inadequate
concealment of allocations, a question mark is
used when not enough information is given in the
paper to make a clear judgement. The included
studies have also been screened for mentioning
conﬂicts of interest.
Quality assessment of the current systematic review
AMSTAR (which stands for A MeaSurement Tool
to Assess systematic Reviews) is used by an
independent researcher to assess the
methodological quality of the current review (Shea
et al. 2007). The goals of the AMSTAR include
creating valid, reliable and useable instruments to
differentiate between systematic reviews. Besides,
the AMSTAR facilitates the development of high-
quality reviews. The AMSTAR checklist consists
of 11 questions and seems to be a valid and
reliable instrument (Shea et al. 2009).
Figure 1 Flow chart of study selection. [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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Results
The electronic search identiﬁed 6023 papers. After
removing duplications, 4267 papers have been
included in the initial database. These 4267 papers
have been screened on title and abstract by two
reviewers independently (PH and HH). The
reference lists of recent systematic reviews (Flynn
2012; Sturmey 2012; Chen 2013; Hwang &
Kearney 2013; Matson 2013; Vereenooghe &
Langdon 2013; Jennings & Hewitt 2015; Koslowski
et al. 2016; Maber-Aleksandrowicz et al. 2016;
Osugo & Cooper 2016; Unwin et al. 2016) were
studied for relevant papers by these two reviewers
as well. One relevant new paper was found. Both
reviewers read 113 full-text articles and screened
these papers on the inclusion criteria. The main
exclusion reason was the absence of study results
(e.g. narrative articles or study results on
depressive symptoms were not published) (Fig. 1).
A total of 15 papers have been included after full-
text screening. Hand searches in reference lists of
these included papers (also done by reviewers PH
and HH) did not reveal other relevant papers to
include in the ﬁnal database. Therefore, the ﬁnal
database contained 15 papers.
Description of the included studies
Five different types of non-pharmacological
interventions are identiﬁed in the included studies of
this review: CBT, behavioural therapy, exercise
intervention, social problem-solving skills programme
and bright light therapy (BLT). Some of these
interventions are developed for the ID population;
others are adjusted versions of interventions of the
general population. The interventions will be
discussed in the succeeding sections, and the
characteristics of the studies are presented in
Tables 1a and 1b.
Quality assessment of the included studies
According to the Cochrane Risk of Bias Tool, none of
the included papers had a low risk of bias on all
domains and much is unclear because of a lack of
reporting. Two studies scored a low risk of bias on ﬁve
out of seven criteria (Hassiotis et al. 2013; Carraro &
Gobbi 2014). Only one study mentioned no conﬂicts
of interest (Hassiotis et al. 2013). In the other papers,T
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nothing was mentioned about any conﬂicts on this
matter. In Table 2, the details of the quality
assessment are shown.
Non-pharmacological interventions
Cognitive behavioural therapy
Cognitive behavioural therapy is the most common
studied intervention to decrease depressive
symptoms. CBT is a psychotherapy in which
thoughts, beliefs and attitudes are discussed. In
CBT, thoughts are modiﬁed in order to change
mood and behaviour. Eight studies focused on
CBT (Lindsay et al. 1993; McCabe et al. 2006;
McGillivray et al. 2008; Ghafoori et al. 2010;
Hassiotis et al. 2013; McGillivray & Kershaw 2013;
Lindsay et al. 2015; McGillivray & Kershaw 2015).
Three studies were RCTs with follow-up (McCabe
et al. 2006; McGillivray et al. 2008; Hassiotis et al.
2013). Three studies were controlled trials with
pre, post and follow-up measurements (McGillivray
& Kershaw 2013; Lindsay et al. 2015; McGillivray
& Kershaw 2015). The study of Ghafoori et al.
(2010) was a pilot study with one group with pre,
Table 1b Characteristics of included case studies
Author
(year) Study design
Sample
size
Participants
(age, gender and
level of ID) Intervention
Measured
depression
outcome
Results
on depressive
symptoms
Lindsay
et al.
(1993)
Case studies n = 2 Mean age:
24
Cognitive therapy
(duration/frequency
of therapy is unclear).
Zung
Depression
Scale
Both subjects improved
on the Zung Depression
Scale. Suicidal thoughts
decreased in one participant.
1 M/1 F
Mild ID
Follow-up (6 weeks):
reductions on depression
scores maintained.
Matson
(1982)
Case studies n = 4 Mean age:
33.5
Behavioural therapy,
10–35 sessions.
Self-rating
Depression
Scale
BDI
Signiﬁcant decrease of
depressive symptoms on
both scales.3 F/1 M
Follow-up (4–6 months):
treatment effect maintained.
Mild–
moderate ID
Stuart
et al.
(2014)
Case study n = 1 Age: 40.0 Seven sessions of
therapy over 3 months
(simpliﬁed behavioural
activation and daily
audio-bases progressive
muscular relaxation).
GDS-LD# Decrease in depressive
symptoms on the GDS-LD
but still above the cut-off
point.
1 F
Mild ID
No follow-up.
Anderson
& Kazantzis
(2008)
Case studies n = 3 Age range:
19–52
(no mean
published)
Social problem-solving
skills training,
15 individual
sessions.
Adapted Zung
Depression
Scale#
Pretreatment—follow-up:
depression showed a 40%
change in one case and
31% change in another case.
2 M/1 F Follow-up (4 weeks):
improvement maintained.Mild ID
Altabet
et al.
(2002)
Case studies n = 3 Mean age: 57 LT sessions, 30 min
(between 08:00 and
10:00 h), 10.000 lux,
5 days per week
for 12 weeks.
DASH#
(depression
sub-scale)
Positive effects on mood
and sleep patterns.
Follow-up (3 weeks):
treatment gains
maintained; (8 weeks):
increased
depressive symptoms.
1 M/2 F
ABC# (lethargy
and irritability
sub-scale)
Profound ID
Mood chart
#Measurements especially developed for people with ID.
ABC, Aberrant Behavior Checklist; BDI, Beck Depression Inventory; DASH, Diagnostic Assessment for the Severely Handicapped; F, female; GDS-LD,
Glasgow Depression Scale for people with learning disabilities; ID, intellectual disability; LT, light therapy; M, male.
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post and follow-up measurements. Two cases were
described in the study of Lindsay et al. (1993).
Seven of these studies reported signiﬁcantly
decreased depression symptoms after CBT; one high-
quality study (Hassiotis et al. 2013) did not ﬁnd
signiﬁcant treatment effects. In the study of Lindsay
et al. (2015), no signiﬁcant effect was found in the Brief
Symptom Inventory Depression Scale, but they did
found signiﬁcant reductions in self-reported
depression and carer-reported depression (Glasgow
Depression Scale). In six of the seven studies with
positive results, the improvement maintained at
follow-up. Based on the results and quality of the
included studies, CBT seems to be an effective
intervention to decrease depressive symptoms in adults
with ID, although there are some conﬂicting results.
Behavioural therapy
In three studies, the effect of behavioural therapy on
depressive symptoms has been investigated (Matson
1982; Stuart et al. 2014; Jahoda et al. 2015).
Table 2 Quality assessment of the included studies
Selection bias
(random
sequence
generation)
Selection bias
(allocation
concealment)
Performance bias
(blinding of
participants and
personnel)
Detection bias
(blinding of
outcome
assessment)
Attrition bias
(incomplete
outcome data)
Reporting
bias
(selective
reporting)
Other
sources
of bias
Matson
(1982)
    + ? 
Lindsay
et al. (1993)
    + ? 
Altabet
et al. (2002)
    + ? 
Heller et al.
(2004)
? ? + + + ? +
McCabe
et al. (2006)
? ? + + + ? 
Anderson &
Kazantzis
(2008)
   + + ? ?
McGillivray
et al. (2008)
? ? + + + ? 
Ghafoori
et al. (2010)
? ?  + + ? 
Hassiotis
et al. (2013)
? + + + + ? +
McGillivray
& Kershaw
(2013)
? ? ? + ? ? ?
Carraro &
Gobbi
(2014)
+  + + + ? +
Stuart et al.
(2014)
   + + ? 
Jahoda et al.
(2015)
  +  + ? 
McGillivray
& Kershaw
(2015)
   + + ? +
Lindsay
et al. (2015)
  + + + ? +
‘+’ = low risk; ‘’ = high risk; ‘?’ = unclear.
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Behavioural therapy is based on the theory that a large
part of human behaviour is learnt from the
environment. In all three studies, participants with
mild ID have been included; Matson (1982) and
Jahoda et al. (2015) also included participants with
moderate or severe ID. None of these three studies on
behavioural therapy used control groups next to the
experimental groups. In the feasibility study of Jahoda
et al. (2015), 21 participants were included in a one
group study with pre, post and follow-up
measurements. Matson (1982) and Stuart et al.
(2014) reported case studies (respectively n = 4 and
n = 1). Depressive symptoms were (signiﬁcantly)
decreased after behavioural therapy in all three
studies. The patient in the study of Stuart et al. (2014)
still had a depression score above the cut-off point
after the intervention. In the studies of Matson (1982)
and Jahoda et al. (2015), the reduction of depressive
symptoms maintained at follow-up. Because of the
small sample sizes and no use of control groups in the
aforementioned studies, the results on behavioural
therapy on decreasing depressive symptoms in adults
with ID must be interpreted with caution.
Exercise intervention
In two RCTs, the effect of exercise on depressive
symptoms has been investigated (Heller et al. 2004;
Carraro & Gobbi 2014). Participants in the study of
Heller et al. (2004) participated in a 12-week (3days per
week, 2 h a day), health promotion programme, which
consisted of 1 h exercise and 1 h health education per
day. The participants in the study of Carraro & Gobbi
(2014) participated in a short-term group-based
exercise programme (12 weeks, 2 times a week, 1 h
sessions). Both studies contained an intervention
group and a control group and reported signiﬁcant
reductions on depressive symptoms in the intervention
group. Unfortunately, both studies did not mention
any follow-up measurements. Based on these two
studies, we can conclude that exercise interventions to
decrease depressive symptoms are promising.
Social problem-solving skills programme
The only study that focused on social problem-
solving skills was a multiple single-case study with
three participants (Anderson & Kazantzis 2008).
Participants in this study had mild ID and got 15
individual sessions of social problem-solving skills
training where they were trained to solve the problems
that they encountered in daily life. No control group
has been used in this study. Reduction of depressive
symptoms was seen in two out of three participants, in
whom improvement maintained at the 4-week follow-
up. This study should be seen as a ﬁrst exploration of
the potential of problem-solving skills programmes,
because of the poor design of this study.
Bright light therapy
Altabet et al. (2002) published three case studies
investigating the effect of BLT on depressive
symptoms. The participants had a profound ID and
participated in a 12-week, ﬁve days a week, BLT
programme (no control group). Participants got BLT
in the morning with a 10.000 lux light box. Positive
effects on mood were found, but beneﬁcial treatment
effects were not uniform. At 3-week follow-up,
treatment gains maintained. The 8-week follow-up
showed increased depressive symptoms. As this study
only contains case reports, it should be seen as a ﬁrst
consideration of the use of BLT to decrease
depressive symptoms in adults with ID.
Quality assessment of the current systematic review
The current study was evaluated by an independent
researcher and scored 8 out of 11 points. According to
AMSTAR, the strengths of this review are the use of
an a priori design, the duplicate study selection and
data extraction and Tables 1 and 2 providing
characteristics of the included studies.
Discussion
The current systematic review contains 15 studies
evaluating the effect of a total of ﬁve different non-
pharmacological interventions to decrease depressive
symptoms in adults with ID. These ﬁve different types
of non-pharmacological interventions are similar to
those found by Holvast et al. (2017) in the elderly
population with depression in primary care. Based on
our study, we can conclude that CBT is an effective
non-pharmacological intervention to decrease
depressive symptoms in adults with mild or moderate
ID (McCabe et al. 2006; McGillivray et al. 2008;
McGillivray & Kershaw 2013; Lindsay et al. 2015;
McGillivray & Kershaw 2015). However, these results
must be interpreted with caution because of the
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methodological problems of some studies as seen in
the quality assessment. In the general population,
CBT is a widely used effective treatment for
depression (Butler et al. 2006). CBT can be used in
the mild to moderate ID population to decrease
depressive symptoms as well, although more RCTs
are needed to establish its usefulness in clinical
practice. The main part of the included studies in this
paper includes interventions for people with mild or
moderate ID. In only two studies, people with severe
or profound ID have been included, even though it is
known that they can suffer from depression as well
(Cooper et al. 2007; Hermans et al. 2013). In general,
conducting intervention studies in the ID population
is challenging. For instance, ethical dilemmas,
speciﬁc living conditions of people with ID,
dependence on professional staff, a difﬁcult informed
consent procedure, the burden of the measurements
and challenging behaviour are issues researchers are
confronted with when conducting intervention
studies in this population (Oliver et al. 2002; Hamers
et al. 2017). This might be an explanation why
intervention studies with adults with severe ID are
even more scarce. In the 1980s, Matson already
published about behavioural therapy for adults with
ID and depression. Unfortunately, none of the studies
on behavioural therapy included in this review used
control groups (Matson 1982; Stuart et al. 2014;
Jahoda et al. 2015). Therefore, we cannot conclude
with certainty that behavioural therapy is responsible
for the decrease in depressive symptoms. However, as
positive results are published in these papers, it seems
promising.
In the two studies (RCTs) investigating exercise as
a non-pharmacological treatment to decrease
depressive symptoms, intervention groups as well as
control groups have been used (Heller et al. 2004;
Carraro & Gobbi 2014). Both studies reported
positive results in decreasing depressive symptoms. In
the study of Heller et al. (2004), participants got
health education and exercise, and in the study of
Carraro & Gobbi (2014), participants got exercise
only, which makes it hard to compare these two
exercise studies. Despite this fact, exercise
interventions seem promising interventions to
decrease depression in adults with ID without
psychical limitations and should be further studied.
The study of Anderson & Kazantzis (2008) was the
only study in this review focusing on social problem-
solving skills programme. Unfortunately, this was a
multiple single-case study with only three
participants, which makes it hard to draw any
conclusions about the effect of this intervention on
decreasing depressive symptoms (Anderson &
Kazantzis 2008). BLT in adults with profound ID is
studied by Altabet et al. 2002. Positive effects were
seen on mood, but no conclusions can be drawn
because of the small sample size and no control group
(Altabet et al. 2002), so more research is needed. The
recent published pilot study with promising results of
Hermans et al. (2017) is the ﬁrst step towards more
insight into the effect of BLT as a treatment for
depression in adults with ID.
A large part of the 15 included studies of this review
are case reports or studies with a small sample size.
Some of the reviewed studies also have
methodological problems, for example, no control
group or no follow-up. Despite the fact that a large
number of adults with ID suffer from depressive
symptoms, limited well-conducted studies are carried
out to evaluate the effect of non-pharmacological
interventions to decrease depressive symptoms.
The strength of the current systematic review is that
the whole study selection (from title/abstract to full
text) and the quality assessment are done by two
reviewers independently. Another strength of this
study is that there was no restriction on publication
year, so all relevant studies published before the start of
this study are screened. Besides, the study protocol of
this systematic review was registered at the start of the
study, which makes the current systematic review
transparent. Themethodological quality of the current
study was assessed with the AMSTAR checklist (Shea
et al. 2007) by an independent researcher and received
an AMSTAR score of 8 (out of 11).
A limitation of the current systematic review is the
small number of papers that could be included
because of the inclusion criteria. Many studies were
excluded because of lack of data on studymethods and
outcome measures. For example, in several papers,
the IQ level of participants was not mentioned.
Further, depressive outcome measures were not
reported in quite a few papers, for example, in the case
series of Tsiouris (2007). Because of the small number
of papers included in our review, which are spread
over ﬁve different kinds of interventions, a meta-
analysis on the effect of the non-pharmacological
treatments was unfortunately not possible. We did not
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use the ‘grey literature’ in this systematic review. So
papers could have been missed. Third, this review is
limited by only including papers published in English.
Fourth, the included studies are very different in study
design, which makes them hard to compare with each
other.
The used tool to evaluate the quality of the studies
(the Cochrane Risk of Bias Tool) is actually designed
for (randomised) controlled trials. As for a more
pragmatic approach, we used it to evaluate all the
study designs of the included papers. Eventually, the
use of this speciﬁc tool emphasised the poor quality of
most of the studies. It is well known that there is a
possibility of publication bias of papers with positive
outcomes (Dickersin et al. 1987; Easterbrook et al.
1991; Turner et al. 2008; Luijendijk & Koolman 2012)
and therefore, papers with negative outcomes can be
missed, which may have inﬂuenced the results of the
current review.
In conclusion, currently CBT is the most well-
studied non-pharmacological intervention for
depression in people with ID, which seems to be
effective as well in the mild and moderate ID
population. Other promising interventions are
exercise and possibly behavioural therapy and BLT.
Although it is known that performing an RCT in
adults with ID (and depression) can be challenging,
we emphasise that further research, preferably
RCTs, is needed to grow the evidence-base for
non-pharmacological interventions for people with
ID and depression. In this way, the
non-pharmacological treatment options in this
population can be expanded, which is especially
important for those with severe or profound ID
who can often only rely on pharmacological
treatments.
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Appendix 1
Search strategies
Embase.com
(‘depression’/exp OR ‘mental health’/exp OR ‘mental
disease’/de OR ‘mental patient’/de OR ‘mood
disorder’/de OR ‘major affective disorder’/de OR
‘minor affective disorder’/de OR (depressi* OR
bipolar* OR (season* NEAR/3 affecti*) OR dysphori*
OR dysthymi* OR melancholi* OR pseudodementi*
OR psychopatholog* OR ((mental* OR psychiatr*)
NEAR/3 (health* OR disorder* OR disease* OR
difﬁcult* OR comorbid* OR co-morbid*)) OR
((mood OR affect*) NEAR/3 disorder*)):ab,ti) AND
(‘psychiatric treatment’/de OR ‘electroconvulsive
therapy’/exp OR ‘psychotherapy’/exp OR ‘physical
medicine’/exp OR ‘exercise’/exp OR
‘chronotherapy’/exp OR ((non NEXT/1 pharmac*)
OR nonpharmac* OR psychotherap* OR
physiotherap* OR phototherap* OR kinesiotherap*
OR kinesitherap* OR exercis* OR dramatherap* OR
storytell* OR mindfulness* OR ((psychiatr* OR
behav* OR cognit* OR psycho*OR dance OR activit*
OR activat* OR running OR movement* OR
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physical* OR light OR group OR electroconvuls* OR
drama OR socioemotion* OR emotion* OR mental*)
NEAR/3 (treat* OR therap* OR interven*)) OR
psychoeducat* OR ‘therapeutic work’ OR
chronotherap* OR CBT):ab,ti) AND (‘intellectual
impairment’/de OR ‘mental deﬁciency’/exp OR
‘developmental disorder’/de OR (((intellectual* OR
mental* OR learning) NEXT/1 (impair* OR disab*
OR deﬁcien* OR handicap* OR retard*)) OR
(developmental* NEXT/1 (disorder* OR disab*)) OR
(Down* NEAR/3 syndrome*)):ab,ti) AND [english]/
lim NOT (‘juvenile’/exp NOT adult/exp)
MEDLINE Ovid
(exp ‘Depression’/ OR exp ‘Mood Disorders’/ OR
‘mental health’/ OR ‘Mental Disorders’/ OR
‘Mentally Ill Persons’/ OR ‘Bipolar Disorder’/ OR
(depressi* OR bipolar* OR (season* ADJ3 affecti*)
OR dysphori* OR dysthymi* OR melancholi* OR
pseudodementi* OR psychopatholog* OR ((mental*
OR psychiatr*) ADJ3 (health* OR disorder* OR
disease* OR difﬁcult* OR comorbid* OR co-
morbid*)) OR ((mood OR affect*) ADJ3
disorder*)).ab,ti.) AND (‘Psychiatric Somatic
Therapies’/ OR exp ‘Convulsive Therapy’/ OR exp
‘Psychotherapy’/ OR ‘Physical and Rehabilitation
Medicine’/ OR ‘Psychiatric Rehabilitation’/ OR exp
‘Physical Therapy Modalities’/ OR exp ‘exercise’/ OR
‘chronotherapy’/ OR ((non ADJ pharmac*) OR
nonpharmac* OR psychotherap* OR physiotherap*
OR phototherap* OR kinesiotherap* OR
kinesitherap* OR exercis* OR dramatherap* OR
storytell* OR mindfulness* OR ((psychiatr* OR
behav* OR cognit* OR psycho* OR dance OR
activit* OR activat* OR running OR movement* OR
physical* OR light OR group OR electroconvuls*
OR drama OR socioemotion* OR emotion* OR
mental*) ADJ3 (treat* OR therap* OR interven*))
OR psychoeducat* OR ‘therapeutic work’ OR
chronotherap* OR CBT).ab,ti.) AND (exp
‘Intellectual Disability’/ OR ‘Developmental
Disabilities’/ OR (((intellectual* OR mental* OR
learning) ADJ (impair* OR disab* OR deﬁcien* OR
handicap* OR retard*)) OR (developmental* ADJ
(disorder* OR disab*)) OR (Down* ADJ3
syndrome*)).ab,ti.) AND english.la. NOT ((exp
child/ OR exp infant/ OR Adolescent/) NOT exp
adult/)
PsycINFO Ovid
(exp ‘Depression (emotion)’/ OR exp ‘Affective
Disorders’/ OR ‘mental health’/ OR ‘Mental
Disorders’/ OR ‘Bipolar Disorder’/ OR (depressi* OR
bipolar* OR (season* ADJ3 affecti*) OR dysphori*
OR dysthymi* OR melancholi* OR pseudodementi*
OR psychopatholog* OR ((mental* OR psychiatr*)
ADJ3 (health* OR disorder* OR disease* OR
difﬁcult* OR comorbid* OR co-morbid*)) OR
((mood OR affect*) ADJ3 disorder*)).ab,ti.) AND
(‘Physical Treatment Methods’/ OR exp
‘Phototherapy’/ OR exp ‘Electroconvulsive Shock
Therapy’/ OR exp ‘Psychotherapy’/ OR exp ‘Physical
Therapy’/ OR exp ‘exercise’/ OR ((non ADJ
pharmac*) OR nonpharmac* OR psychotherap* OR
physiotherap* OR phototherap* OR kinesiotherap*
OR kinesitherap* OR exercis* OR dramatherap* OR
storytell* OR mindfulness* OR ((psychiatr* OR
behav* OR cognit* OR psycho* OR dance OR
activit* OR activat* OR running OR movement* OR
physical* OR light OR group OR electroconvuls* OR
drama OR socioemotion* OR emotion* OR mental*)
ADJ3 (treat* OR therap* OR interven*)) OR
psychoeducat* OR ‘therapeutic work’ OR
chronotherap* OR CBT).ab,ti.) AND (exp
‘Intellectual Development Disorder’/ OR
‘Developmental Disabilities’/ OR (((intellectual* OR
mental* OR learning) ADJ (impair* OR disab* OR
deﬁcien* OR handicap* OR retard*)) OR
(developmental* ADJ (disorder* OR disab*)) OR
(Down* ADJ3 syndrome*)).ab,ti.) AND english.la.
NOT ((100.ag. OR 200.ag.) NOT 300.ag.)
Cochrane
((depressi* OR bipolar* OR (season* NEAR/3
affecti*)ORdysphori*ORdysthymi*ORmelancholi*
OR pseudodementi* OR psychopatholog* OR
((mental* OR psychiatr*) NEAR/3 (health* OR
disorder* OR disease* OR difﬁcult* OR comorbid*
OR co-morbid*)) OR ((mood OR affect*) NEAR/3
disorder*)):ab,ti) AND (((non NEXT/1 pharmac*)
OR nonpharmac* OR psychotherap* OR
physiotherap* OR phototherap* OR kinesiotherap*
OR kinesitherap* OR exercis* OR dramatherap* OR
storytell* OR mindfulness* OR ((psychiatr* OR
behav* OR cognit* OR psycho*OR dance OR activit*
OR activat* OR running OR movement* OR
physical* OR light OR group OR electroconvuls* OR
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drama OR socioemotion* OR emotion* OR mental*)
NEAR/3 (treat* OR therap* OR interven*)) OR
psychoeducat* OR ‘therapeutic work’ OR
chronotherap* OR CBT):ab,ti) AND ((((intellectual*
OR mental* OR learning) NEXT/1 (impair* OR
disab* OR deﬁcien* OR handicap* OR retard*)) OR
(developmental* NEXT/1 (disorder* OR disab*)) OR
(Down* NEAR/3 syndrome*)):ab,ti) NOT ((child*
OR infan* OR adolescen*) NOT adult*)
Web of Science
TS = (((depressi* OR bipolar* OR (season* NEAR/2
affecti*) OR dysphori* OR dysthymi* OR
melancholi* OR pseudodementi* OR
psychopatholog* OR ((mental* OR psychiatr*)
NEAR/2 (health* OR disorder* OR disease* OR
difﬁcult* OR comorbid* OR co-morbid*)) OR
((mood OR affect*) NEAR/2 disorder*))) AND
(((non NEAR/1 pharmac*) OR nonpharmac* OR
psychotherap* OR physiotherap* OR phototherap*
OR kinesiotherap* OR kinesitherap* OR exercis* OR
dramatherap* OR storytell* OR mindfulness* OR
((psychiatr* OR behav* OR cognit* OR psycho* OR
dance OR activit* OR activat* OR running OR
movement* OR physical* OR light OR group OR
electroconvuls* OR drama OR socioemotion* OR
emotion* OR mental*) NEAR/2 (treat* OR therap*
OR interven*)) OR psychoeducat* OR ‘therapeutic
work’ OR chronotherap* OR CBT)) AND
((((intellectual* OR mental* OR learning) NEAR/1
(impair* OR disab* OR deﬁcien* OR handicap* OR
retard*)) OR (developmental* NEAR/1 (disorder*
OR disab*)) OR (Down* NEAR/2 syndrome*)))
NOT ((child* OR infan* OR adolescen*) NOT
adult*)) AND LA = (english)
Google Scholar
Depression|depressive ‘non pharmaceutical’|
psychotherapy|phototherapy|’psychiatric|behavior|
cognitive|light therapy’ ‘intellectual|intellectually|
mental|mentally impairment|disabled|disability|
deﬁciency|handicap|retarded|retardeation’.
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